BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 717379)

  • 1. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
    Lamers CB; Festen HP; van Tongeren JH
    Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.
    Richardson CT; Walsh JH
    N Engl J Med; 1976 Jan; 294(3):133-5. PubMed ID: 616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of systemic mastocytosis with histamine H2 receptor antagonists.
    Johnson GJ; Silvis SE; Roitman B; Blumenthal M; Gilbert HS
    Am J Gastroenterol; 1980 Dec; 74(6):485-9. PubMed ID: 6782861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors].
    Bonfils S; Bernier JJ; Mignon M; Hautefeuille P; Corbic M; Marteau J
    Nouv Presse Med; 1975 Oct; 4(33):2377-81. PubMed ID: 653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dose-response curves obtained with metiamide in the Zollinger-Ellison syndrome].
    Mignon M; Galmiche JP; Bonfils S
    Biol Gastroenterol (Paris); 1975; 8(3):239-44. PubMed ID: 764881
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Treatment of Zollinger-Ellison syndromes with metiamide or cimetidine. Potential risk of hyperimmunization manifestations].
    Moulias R; Congy F
    Nouv Presse Med; 1976 Jan; 5(3):149-50. PubMed ID: 4772
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)].
    Hausamen TU; Fritsch WP; Scholten T; Jungblut R; Strohmeyer G
    Dtsch Med Wochenschr; 1977 Nov; 102(47):1709-12. PubMed ID: 21785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.
    Lambers CB; Lind T; Moberg S; Jansen JB; Olbe L
    N Engl J Med; 1984 Mar; 310(12):758-61. PubMed ID: 6142418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zollinger-Ellison syndrome unresponsive to cimetidine.
    Groarke JF; Haggstrom GD; Halpern NB; Hirschowitz BI
    Am J Gastroenterol; 1979 Aug; 72(2):168-70. PubMed ID: 474557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Danne O; Maria J
    Nouv Presse Med; 1977 Nov; 6(38):3544-5. PubMed ID: 23518
    [No Abstract]   [Full Text] [Related]  

  • 14. Metiamide treatment in five patients with Zollinger-Ellison syndrome.
    Bonfils S; Bernier JJ; Mignon M; Lambert R; Bernades P; L'Hirondel C; Accary JP; Kloeti G
    Digestion; 1977; 15(1):43-52. PubMed ID: 838177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Kloeti G
    Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussions with the speakers on histamine-H2-receptor antagonists. 21 April 1978, Vienna].
    Acta Med Austriaca Suppl; 1978; 10():1-11. PubMed ID: 32718
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma-secretin in management of cimetidine therapy for Zollinger-Ellison syndrome.
    Straus E; Greenstein RJ; Yalow RS
    Lancet; 1978 Jul; 2(8080):73-5. PubMed ID: 78299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration: a review.
    Richardson CT
    Gastroenterology; 1978 Feb; 74(2 Pt 2):366-70. PubMed ID: 23338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with H2 receptor antagonists. Zollinger-Ellison Syndrome.
    Siepler JK; Donahue P; Campagna K; Bombeck CT
    IMJ Ill Med J; 1978 Apr; 153(4):283-7. PubMed ID: 25249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.